VentrAssistTM LVAD as a Bridge to Cardiac Transplantation - Pivotal Trial

Status unconfirmed · Phase 3

Conditions studied: End-stage Heart Failure, Cardiomyopathies

In brief

The purpose of this study is to evaluate the safety and effectiveness of VentrAssistTM LVAD in individuals who are awaiting heart transplants.

Key facts

Study ID
NCT00483197
Run by
Ventracor
People needed
140
Starts
2007-06-01
Expected to finish
2010-06-01
Last updated by the study team
2009-09-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.